Newborns and Alzheimer's Patients Have Elevated Blood Levels of Phosphorylated Tau

Newborns and Alzheimer's patients have elevated blood levels of phosphorylated tau

Newborn babies and patients with Alzheimer's disease share an unexpected biological trait: elevated levels of a well-known biomarker for Alzheimer's.

Newborns have elevated levels of a biomarker for Alzheimer's

Newborn babies and patients with Alzheimer's disease share an unexpected biological trait: elevated levels of a well-known biomarker for Alzheimer's, as shown in a study led by researchers at the University of Gothenburg and published in Brain Communications.

Newborns and Alzheimer’s Patients Share a Brain Protein Spike

A new study has revealed that newborn babies and Alzheimer’s patients both have elevated levels of the same protein, p-tau217, in their blood. While this protein is a key marker of brain degeneration in Alzheimer’s, in newborns it appears to support healthy brain growth and development.

Developing BBB-ASL as non-invasive early biomarker of Alzheimer's Disease (DEBBIE)